New combo therapy aims to delay prostate cancer progression
NCT ID NCT05893381
First seen Jan 07, 2026 · Last updated May 20, 2026 · Updated 18 times
Summary
This study is for men with prostate cancer that has spread to 1-3 small spots in the body (oligometastatic). It compares standard radiation alone to radiation followed by a targeted radioactive drug called Lu-PSMA. The goal is to see if the combination can keep the cancer from growing longer. About 70 men will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UO Medicina Nucleare, AUSL della Romagna
RECRUITINGCesena, FC, 47521, Italy
Contact Email: •••••@•••••
-
UO Medicina Nucleare, IRCCS IRST
RECRUITINGMeldola, FC, 47014, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.